iiinova — where your digital self keeps evolving

Reposted by Franck Touret

IRD @ird-fr.bsky.social · 15/06/2026

🦠 Fièvre de la Vallée du Rift, virus de Crimée-Congo, hantavirus… Face à ces fièvres hémorragiques virales, des chercheurs de l'Unité des Virus Emergents (UVE) ont misé sur une stratégie de réponse directe à l'épidémie : le repositionnement de médicaments. Plus d'infos: lemag.ird.fr/fr/combattre...

041

Reposted by Franck Touret

Mathieu M.J.E. Rebeaud @chercheurjuteux.com · 17/02/2026

How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid‐19 Revue entre Paris, Dijon, Marseille avec @franckdrtourte.bsky.social et le juteux @nathanpsmad.bsky.social ascpt.onlinelibrary.wiley.com/doi/10.1111/...

ascpt.onlinelibrary.wiley.com

How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid‐19

Pharmacological pitfalls and challenges in drug repurposing for emerging pathogens: lessons from COVID-19.

052

Franck Touret @franckdrtourte.bsky.social · 12/05/2025

Just published in Antiviral research! 3D Liver Spheroids in the Fight Against Haemorrhagic Fever Viruses t.co/FuxQ76acrg @ird-fr.bsky.social @univ-amu.fr @insermpacacorse.bsky.social

t.co

https://doi.org/10.1016/j.antiviral.2025.106188

120

Franck Touret @franckdrtourte.bsky.social · 14/02/2025

🔬 New Research Breakthrough: Broad-Spectrum Inhibitors for Enteroviruses🦠Enteroviruses (EV) are a diverse group of viruses that can cause a range of illnesses, from mild fever to severe neurological complications.

122

Franck Touret @franckdrtourte.bsky.social · 30/01/2025

🚨 New Insights on Hemorrhagic Fever Viruses & 3D Cell Culture Models 🦠 In the ongoing battle against hemorrhagic fever viruses (HFVs), the development of effective antiviral strategies remains a critical challenge.

100

Franck Touret @franckdrtourte.bsky.social · 19/01/2024

Fresh from the oven our study on the functional diversity of cross-reacting antibodies generated during SARS-CoV-2 infection and illustrate how the balance between neutralizing and enhancing Abs facilitate variant emergence. doi.org/10.1080/2222...

000

Franck Touret @franckdrtourte.bsky.social · 28/11/2023

New laboratory preprint Translational study in which we investigated the resistance barrier of two protease inhibitors (nirmatrelvir and ensitrelvir). www.biorxiv.org/content/10.1...

130